因美纳ILMN财报
Nasdaq · 工业 · 实验室分析仪器
因美纳是总部位于美国加利福尼亚州圣迭戈的生物技术企业，成立于1998年4月，专注研发、生产及销售用于分析基因变异与生物功能的集成系统，产品及服务覆盖测序、基因分型、基因表达、蛋白质组学等领域，业务遍及全球超155个国家和地区。
主要股东
| 股东 | 持股比例 | 股数 | 变动 | 截至 |
|---|---|---|---|---|
| Illumina, Inc. | 14.50% | 4.5M | — | 2024-08-14 |
| BlackRock, Inc. | 11.30% | 18.1M | ▲ +2.90pp | 2024-07-08 |
| OF ABOVE PERSONS | 10.60% | 16.8M | — | 2024-12-05 |
| The Vanguard Group | 10.05% | 15.9M | ▲ +0.07pp | 2024-12-06 |
| Nos. of above persons | 3.36% | 5.3M | ▼ -2.08pp | 2023-12-05 |
内部人交易
Net 90d: −$407.0K · buys $23.6K / sells $430.6K时间范围:
类型:
身份:
| 内部人 | 身份 | 类型 | ||||
|---|---|---|---|---|---|---|
| 2026-03-31 | Meister Keith A. | Director | Grant | 161 | $131.55 | $21.2K |
| 2026-03-31 | Ullem Scott B. | Director | Grant | 190 | $131.55 | $25.0K |
| 2026-03-05 | Steven Barnard | SVP, Chief Technology Officer | Grant | 7.6K | $128.24 | $975.0K |
| 2026-03-05 | Ericksen Scott D | VP, Chief Accounting Officer | Grant | 3.2K | $128.24 | $412.5K |
| 2026-03-05 | Ankur Dhingra | SVP, Chief Financial Officer | Grant | 9.4K | $128.24 | $1.20M |
| 2026-03-05 | Patricia Leckman | SVP, Chief People Officer | Grant | 6.3K | $128.24 | $810.1K |
| 2026-03-05 | Jacob Thaysen | Chief Executive Officer | Grant | 25.7K | $128.24 | $3.30M |
| 2026-03-05 | Pegels Kevin Carl | Chief of Global Operations | Grant | 6.3K | $128.24 | $810.1K |
| 2026-03-05 | Wedel Christensen Jakob | SVP, Strategy/Corp Development | Grant | 5.6K | $128.24 | $720.1K |
| 2026-03-05 | Davies Scott M | Chief Legal Officer | Grant | 5.8K | $128.24 | $750.1K |
1–10 of 20
第 1 页 / 共 2 页